Cancer
Tyrosinase 206-214 (HLA-A*24:02) AFLPWHRLF
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11446_1
Description
AFLPWHRLF is a tyrosinase epitope recognized by HLA-A24 restricted, tumor-infiltrating lymphocytes (TIL). Therefore it represents a reagent that may be used to generate melanoma-specific T cells for adoptive immunotherapy, as well as in peptide vaccines for HLA-A24+ melanoma patients. AFLPWHRLF is a linear peptidic epitope (epitope ID1353) studied as part of Tyrosinase from Homo sapiens (human), tested in MHC ligand assay
TechData
| Sequence: | AFLPWHRLF |
| Gene: | Tyr |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Tyrosinase |
| Species: | Human |
| Allele: | HLA-A*24:02 |
| Application: | Immune monitoring, Immunohistochemistry, T-cell assays, |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |